To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.
Study sponsor: Neumora Therapeutics, Inc. · NMRA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-04-09Actual
Enrollment · participants18Actual
Source updated2026-03-30Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.